Company · ABCL
AbCellera Biologics Inc.
Nasdaq's symbol directory lists ABCL on Nasdaq as “AbCellera Biologics Inc. - Common Shares”.
In the 12 months to Nov 8, 2026: insiders bought on 4 occasions ($1.5M).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Hayden Michael R bought $1.1M
- Booth Andrew, Chief Financial Officer bought $384K
- Montalbano John S. bought $110K
Every trade (4)
- BUYHayden Michael R bought $570K
- BUYMontalbano John S. bought $110K
- BUYBooth Andrew, Chief Financial Officer bought $384K
- BUYHayden Michael R bought $481K
Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.